Recent advance in aminopeptidase N (APN/CD13) inhibitor research

Current Medicinal Chemistry

Volumn 18, Issue 32, 2011, Pages 5011-5021

  Zhang, X ^a   Fang, H ^a   Zhang, J ^a   Yuan, Y ^a   Xu, W ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Aminopeptidase N; Anti tumor; Inhibitors; Peptidomimetics; Rational drug design; Structure activity relationship

Indexed keywords

1,3,4 THIADIAZOLE DERIVATIVE; 2 AMINO 3 (4 NITROPHENYL)PROPANOIC ACID; 3 AMINO 2 HYDROXY 4 PHENYL BUTANOIC ACID DERIVATIVE; 3 AMINO 2 HYDROXYPHENYLBUTANOIC ACID; 3 PHENYLPROPANE 1,2 DIAMINE DERIVATIVE; ANTINEOPLASTIC AGENT; ARGININE DERIVATIVE; BESTATIN; CHLORAMPHENICOL AMINE DERIVATIVE; CHLORAMPHENICOL DERIVATIVE; LYSINE DERIVATIVE; MICROSOMAL AMINOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE INHIBITOR; N CINNAMOYL LEVO ASPARTIC ACID DERIVATIVE; PEPTIDE HYDROLASE INHIBITOR; PROBESTIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; EXTRACELLULAR MATRIX; HUMAN; IC 50; LIVER CELL CARCINOMA; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD13; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80054862784     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797535155     Document Type: Article

References (45)

1. Rawlings, N.D.; Barrett, A.J. MEROPS: The peptidase database. Nucleic Acids Res., 1999, 27, 325-331. (Pubitemid 29209475)
2. Hooper, N.M. Families of zinc metalloproteases. FEBS. Lett., 1994, 354, 1-6. (Pubitemid 24331694)
3. Pfleiderer, G.; Celliers, P.G. Isolation of an Aminopeptidase from Kidney Particles. Biochem. Z., 1963, 339, 186-189.
4. Look, A.T.; Ashmun, R.A.; Shapiro, L.H.; Peiper, S.C. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest., 1989, 83, 1299-1307. (Pubitemid 19113045)
5. Mina-Osorio, P. The moonlighting enzyme CD13: Old and new functions to target. Trends. Mol. Med., 2008, 14, 361-371.
6. Breljak, D.; Gabrilovac, J.; Boranic, M. Aminopeptidase N/CD13 and haematopoietic cells. Haema., 2003, 4, 453-461. (Pubitemid 37362684)
7. Dixon, J.; Kaklamanis, L.; Turley, H.; Hickson, I.D.; Leek, R.D.; Harris, A.L.; Gatter, K.C. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J. Clin. Pathol., 1994, 47, 43-47. (Pubitemid 24057748)
8. Raynaud, F.; Bauvois, B.; Gerbaud, P.; Evain-Brion, D. Characterization of specific proteases associated with the surface of human skin fibroblasts, and their modulation in pathology. J. Cell. Physiol., 1992, 2, 378-385.
9. Piela-Smith, T.H.; Korn, J.H. Aminopeptidase N: A constitutive cell-surface protein on human dermal fibroblasts. Cell. Immunol., 1995, 162, 42-48.
10. Thielitz, A.; Reinhold, D.; Vetter, R.; Bank, U.; Helmuth, M.; Hartig, R.; Wrenger, S.; Wiswedel, I.; Lendeckel, U.; Kahne, T.; Neubert, K.; Faust, J.; Zouboulis, C.C.; Ansorge, S.; Gollnick, H. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation. J. Invest. Dermatol., 2007, 127, 1042-1051. (Pubitemid 46625127)
11. Gabrilovac, J.; Cupic, B.; Breljak, D.; Zekusic, M.; Boranic, M. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes. Immunol. Lett., 2004, 91, 39-47. (Pubitemid 38147744)
12. Ikeda, N.; Nakajima, Y.; Tokuhara, T.; Hattori, N.; Sho, M.; Kanehiro, H.; Miyake, M. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma. Clin. Cancer. Res., 2003, 9, 1503-1508. (Pubitemid 36418408)
13. Dan, H.; Tani, K.; Hase, K.; Shimizu, T.; Tamiya, H.; Biraa, Y.; Huang, L.; Yanagawa, H.; Sone, S. CD13/aminopeptidase N in collagen vascular diseases. Rheumatol. Int., 2003, 23, 271-276. (Pubitemid 37518609)
14. Shimizu, T.; Tani, K.; Hase, K.; Ogawa, H.; Huang, L.; Shinomiya, F.; Sone, S. CD13/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis. Rheum., 2002, 46, 2330-2338.
15. Luan, Y.P.; Xu, W.F. The structure and main functions of aminopeptidase N. Curr. Med. Chem., 2007, 14, 639-647.
16. Gullbo, J.; Wickstrom, M.; Larsson, R.; Nygren, P. Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Science, 2011, 102, 501-508.
17. Umezawa, H.; Aoyagi, T.; Suda, H.; Hamada, M.; Takeuchi, T. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiot, 1976, 29, 97-99.
18. Talmadge, J.E.; Lenz, B.F.; Pennington, R.; Long, C.; Phillips, H.; Schneider, M.; Tribble, H. Immunomodulatory and therapeutic properties of bestatin in mice. Cancer Res., 1986, 46, 4505-4510. (Pubitemid 16046879)
19. Bauvois, B.; Dauzonne, D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects. Med. Res. Rev., 2006, 26, 88-130. (Pubitemid 43986471)
20. Xu, W.F.; Li, Q.B. Progress in the development of aminopeptidase N (APN/CD13) inhibitors. Curr. Med. Chem. Anticancer Agents, 2005, 5, 281-301.
21. Zhang, X.P.; Xu, W.F. Aminopeptidase N (APN/CD13) as a target for anticancer agent design. Curr. Med. Chem., 2008, 15, 2850-2865.
22. Aoyagi, T.; Yoshida, S.; Nakamura, Y.; Shigihara, Y.; Hamada, M.; Takeuchi, T. Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. I. Taxonomy, production, isolation, physico-chemical properties and biological activities. J. Antibiot., 1990, 43, 143-148. (Pubitemid 20069961)
23. Nagai, M.; Kojima, F.; Naganawa, H.; Hamada, M.; Aoyagi, T.; Takeuchi, T. Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ716-m3. J. Antibiot., 1997, 50, 82-84. (Pubitemid 27078063)
24. Chung, M.C.; Lee, H.J.; Chun, H.K.; Lee, C.H.; Kim, S.I.; Kho, Y.H. Bestatin analogue from Streptomyces neyagawaensis SL-387. Biosci. Biotechnol. Biochem., 1996, 60, 898-900.
25. Luan, Y.P.; Wang, X.J.; Zhu, H.W.; Qu, X.J.; Fang, H.; Xu, W.F. The Synthesis and Activity Evaluation of a Bestatin Derivative (LYP) as an Aminopeptidase N Inhibitor. Lett. Drug Des. Disco., 2009, 6, 420-423.
26. Luan, Y.P.; Wang, Q.A.; Liu, N.; Mou, J.J.; Jiao, X.J.; Fang, H.; Li, M.Y.; Xu, W.F. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor. Anti-Cancer Drugs, 2011, 22, 99-103.
27. Luan, Y.P.; Ma, C.H.; Sui, Z.G.; Wang, X.J.; Feng, J.H.; Liu, N.; Jing, F.B.; Wang, Y.; Li, M.Y.; Fang, H.; Xu, W.F. LYP3, a new bestatin derivative for aminopeptidase N inhibition. Med. Chem., 2011, 7, 32-36.
28. Yang, K.H.; Wang, Q.; Su, L.; Fang, H.; Wang, X.J.; Gong, J.Z.; Wang, B.H.; Xu, W.F. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors. Bioorg. Med. Chem., 2009, 17, 3810-3817.
29. Jia, M.R.; Yang, K.H.; Fang, H.; Xu, Y.Y.; Sun, S.W.; Su, Li.; Xu, W.F. Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine. Bioorg. Med. Chem., 2011, doi: 10.1016/j.bmc.2011.07.008.
30. Shang, L.Q.; Wang, Q.; Fang, H.; Mu, J.J.; Wang, X.J.; Yuan, Y.M.; Wang, B.H.; Xu, W.F. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN). Bioorg. Med. Chem., 2008, 16, 9984-9990.
31. Shang, L.Q.; Fang, H.; Zhu, H.W.; Wang, X.J.; Wang, Q.; Mu, J.J.; Wang, B.H.; Kishioka, S.; Xu, W.F. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors. Bioorg. Med. Chem., 2009, 17, 2775-2784.
32. Wang, Q.; Chen, M.Y.; Zhu, H.W.; Zhang, J.; Fang, H.; Wang, B.H.; Xu, W.F. Design, synthesis, and QSAR studies of novel lysine derives as aminopeptidase N/CD13 inhibitors. Bioorg. Med. Chem., 2008, 16, 5473-5481. (Pubitemid 351694481)
33. Wang, Q.; Xu, F.M.; Mou, J.J.; Zhang, J.; Shang, L.Q.; Luan, Y.P.; Yuan, Y.M.; Liu, Y.Z.; Li, M.Y.; Fang, H.; Wang, B.H.; Xu, W.F. Design, Synthesis and Preliminary Activity Evaluation of Novel L-Lysine Derivatives as Aminopeptidase N/CD13 Inhibitors. Protein Pept. Lett., 2010, 17, 847-853.
34. Su, L.; Fang, H.; Yang, K.H.; Xu, Y.Y.; Xu, W.F. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors. Bioorg. Med. Chem., 2011, 19, 900-906.
35. Mou, J.J.; Fang, H.; Jing, F.B.; Wang, Q.; Liu, Y.Z.; Zhu, H.; Shang, L.Q.; Wang, X.J.; Xu, W.F. Design, synthesis and primary activity evaluation of Larginine derivatives as amino-peptidase N/CD13 inhibitors. Bioorg. Med. Chem., 2009, 17, 4666-4673.
36. Mou, J.J.; Fang, H.; Liu, Y.Z.; Shang, L.Q.; Wang, Q.; Zhang, L.; Xu, W.F. Design, synthesis and primary activity assay of bi-or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors. Bioorg. Med. Chem., 2010, 18, 887-895.
37. Tu, G.G.; Li, S.H.; Huang, H.M.; Li, G.; Xiong, F.; Mai, X.; Zhu, H.W.; Kuang, B.; Xu, W.F. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold. Bioorg. Med. Chem., 2008, 16, 6663-6668.
38. Li, S.H.; Li, G.; Huang, H.M.; Xiong, F.; Liu, C.M.; Tu, G.G. The synthesis and preliminary activity assay in vitro of peptide-like derivatives as APN inhibitors. Arch. Pharm. Res., 2008, 31, 1231-1239.
39. Liu, Y.; Shang, L.; Fang, H.; Zhu, H.; Mu, J.; Wang, Q.; Wang, X.; Yuan, Y.; Xu, W. Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13. Bioorg. Med. Chem., 2009, 17, 7398-7404.
40. Li, Q.B.; Fang, H.; Xu, W.F. Novel 3-galloylamido-N'-substituted-2,6- piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 2935-2938. (Pubitemid 46636232)
41. Wang, J.L.; Xu, W.F. The preparation of novel L-iso-glutamine derivatives as potential antitumor agents. J. Chem. Res., 2003, 789-791.
42. Li, Q.B.; Fang, H.; Wang, X.J.; Xu, W.F. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II. Eur. J. Med. Chem., 2010, 45, 1618-1626.
43. Cui, S.X.; Qu, X.J.; Gao, Z.H.; Zhang, Y.S.; Zhang, X.F.; Zhao, C.R.; Xu, W.F.; Li, Q.B.; Han, J.X. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells. Cancer Lett., 2010, 292, 153-162.
44. Inagaki, Y.; Tang, W.; Zhang, L.; Du, G.; Xu, W.; Kokudo, N. Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis. Biosci. Trends., 2010, 4, 56-60.
45. Zhang, X.P.; Fang, H.; Zhu, H.W.; Wang, X.J.; Zhang, L.; Li, M.Y.; Li, Q.B.; Yuan, Y.M.; Xu, W.F. Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione. Bioorg. Med. Chem., 2010, 18, 5981-5987.